Oral Teriflunomide study shows lasting efficacy and safety

Aubagio is an oral treatment approved for MS.

Oral Teriflunomide study shows lasting efficacy and safety

Postby MSUK » Thu Oct 27, 2011 12:43 am


The investigational oral drug teriflunomide (Aubagio) seems to have maintained its effectiveness during up to nine years of follow-up in clinical trial patients with the relapsing form of multiple sclerosis, and no late safety problems have been noticed, researchers said here.

The findings came from open-label extensions of phase II and III studies with teriflunomide, which is now under FDA review as a treatment for relapsing-remitting MS. The results were presented in a series of posters at the joint meeting of the European and American Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS).... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2933
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to Aubagio (teriflunomide)


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service